单次肌注亚硒酸钠在仔猪体内的药代动力学     

赵晶  康世良  李艳华  陈辉 《中国兽医学报》2003,23(2):188-190

按 0 .2 m g/ kg单剂量对健康仔猪肌注亚硒酸钠溶液后 ,研究了其在血液中的药物代谢动力学。结果表明 :血液动力学特征符合一级吸收二室开放模型 ,其理论方程为 :C=0 .1773e- 0 .0 548t+0 .0 72 7e- 0 .0 0 2 6 t- 0 .2 5 0 0 e- 1 3.882 3t。主要动力学参数为 :吸收半衰期 (t1 /2 Ka)为 0 .0 4 99h;达峰时间 (tmax)为 0 .4 2 37h;消除半衰期 (t1 /2β)为 2 71.9311h;曲线下面积 (AU C)为 31.72 6 0 m g/ L·h;表观分布容积 (Vd)为 2 .4 72 1L/ kg。根据单剂量药动学参数 ,计算多剂量给药参数 ,为临床治疗制定给药方案。先导剂量 (D* )为 0 .5 0 89m g/ kg,维持剂量 (D0 )为 0 .2 mg/ kg,给药间隔 (τ)为 192 h,平均稳态血药浓度 (c)为 0 .16 5 2 mg/ L。  相似文献   

新一代驱虫抗生素—莫西菌素     

刘开永  李英伦  周岷江  刘光林 《动物医学进展》2003,24(4):59-62

莫西菌素同伊维菌素一样 ,是一种目前广泛用于兽医临床的广谱、高效、新型大环内酯类驱虫抗生素 ,是美贝霉素家族中的一员。由于其独特的理化性质 ,在国外 ,已被广泛用于治疗奶牛、猪等动物体内外寄生虫病。文章对莫西菌素的理化特性、作用机制、药动学、制剂、药效、耐药性、毒性、残留等进行了较详细地综述 ,同时也介绍了减少耐药性产生的一些方法 ,为该药能在国内应用提供第一手资料 ,以求为兽医临床用药提供参考  相似文献   

Biovailability of ivermectin administered orally to dogs     

C. P. Daurio  E. N. Cheung  A. R. Jeffcoat  B. J. Skelly 《Veterinary research communications》1992,16(2):125-130

The bioavailability of three formulations of ivermectin was determined following oral administration to dogs. The average peak plasma level (C _max) of ivermectin administered in the standard tablet formulation at 6 and 100 µg/kg of body weight was 2.97 and 44.31 ng/g, respectively. This suggest dose-dependent pharmacokinetics.C _max and total ivermectin bioavailability, as assessed from the area under the plasma curve (AUC), were similar between two tablet formulations of ivermectin administered at 100 µg/kg. Furthermore,C _max was similar following administration of radiolabelled ivermectin at 6 µg/kg in either a beef-based chewable formulation or in the standard tablet formulation.  相似文献   

影响水产动物药代动力学的因素   总被引：6，自引：0，他引：6  

湛嘉  李佐卿  康继韬  俞雪均  谢东华  孙大为  杨先乐 《中国兽药杂志》2003,37(12):38-41

对影响水产动物药代动力学的机体因素、药理因素和环境因素进行了综述。影响药动学的因素很多，尤其对于所处环境因素复杂的水产动物来说，除了遗传种属、性别等生理因素和病理、药理等因素外，环境因子尤其是水温能显著影响药代动力学过程。研究不同条件下的药动学，对于合理、正确地使用药物有重要的指导作用。  相似文献   

The pharmacokinetics of thiamphenicol in lactating cows   总被引：2，自引：0，他引：2  

N. Mestorino  M. F. Landoni  M. Alt  J. O. Errecalde 《Veterinary research communications》1993,17(4):295-303

The pharmacokinetics of thiamphenicol were studied after intravenous and intramuscular administration of 25 mg/kg body weight in lactating cows. Distribution (t _1/2) and elimination (t _1/2) half-lives of 6.10±1.39 min and 1.60±0.30 h, respectively, were obtained after intravenous administration. The body clearance was 3.9±0.077 ml/kg per min and the apparent volume of distribution was 1220.79±256.67 ml/kg. The rate at which thiamphenicol appeared in the milk, as indicated by the penetration half-life (t _1/2P) (serum to quarters), was found to be 36.89±11.14 min. The equivalent elimination half-life (t _1/2E) (quarters to serum) from the milk was 3.62±1.06 h and the peak thiamphenicol concentration in the milk was 23.09±3.42 µg/ml at 2.5±0.32 h.After intramuscular injection, the elimination half-life was 2.2±0.40 h, the absorption half-life was 4.02±1.72 min and the peak concentration in the serum was 30.90±5.24 µg/ml at 23±8.4 min. The bioavailability after intramuscular administration approached 100%. The penetration half-life was 50.59±6.87 min, the elimination half-life was 5.91±4.97 h and the mean peak concentration in the milk was 17.37±2.20 µg/ml at 3.4±0.22 h.Abbreviations AUC area under the concentration-time curve - CAP chloramphenicol - C _max peak concentration - IM intramuscular - IV intravenous - TAP thiamphenicol - t _1/2 distribution half-life - t _1/2 elimination half-life - V _c volume of central compartment - V _d volume of distribution  相似文献   

司帕沙星在雏鸡体内药代动力学及残留的研究   总被引：2，自引：0，他引：2  

刘明春  佟恒敏  朱文波  孙相志  何剑斌  赵玉军 《现代畜牧兽医》2004,(11):37-39

选用30日龄健康海兰鸡65只,按5mg／kg体重口服给予司帕沙星,定期采样,以高效液相色谱法测定血浆、肝、肾、心、肺和肌肉中司帕沙星的含量,研究司帕沙星在鸡体内的药动学与残留。结果表明:司帕沙星在血液中经时过程符合一级吸收二室开放模型,其主要动力学参数如下:t1／2α0.9585h,t1／2β11.7447h,tmax0,6514 h,Cmax0.5271 μg／ml,AUC1.7908mg／L／h。肾脏、心脏的药时数据符合一级吸收二项指数方程,其主要动力学参数分别为:t1/2Ka0.3733 h、0.1530h,t1／2k1.3007 h、2.1013h,tmax1.01420h、0.6239 h,Cmax2.1104μg／ml、1.6721 μg／ml,AUC6.51764 mg／L／h、6.2286mg／L／h。司帕沙星在肝脏、肺脏、肌肉中的经时过程符合一级吸收三项指数方程,主要动力学参数分别为t1/2α0.3672 h、0.6156 h、1.5835 h,t1/2β3.9998 h、15.0271 h、12.0103h,tmax0.7458 h、0.7322 h、1.3726 h,Cmax4.4709μg／ml、2.5267μg／ml、0.9760μg／ml,AUC20.893 mg／L／h,27.242 mg／L／h、9.7943mg/L/h。建议司帕沙星在鸡体内的休药期为7d。  相似文献   

多拉菌素在猪体内的药代动力学   总被引：5，自引：0，他引：5  

张继瑜  李剑勇  周绪正  李金善  张梅  徐忠赞  李宏胜  胡俊杰 《畜牧兽医学报》2005,36(7):722-726

对多拉菌素在猪体内进行为期45d的药代动力学研究。长白×杜洛克杂交猪10头,临床健康,驱净寄生虫,体重36～50kg,以300μg/kg体重剂量分别通过静脉和肌肉注射给药。动物给药后在不同时间内分点经颈静脉采血。血浆样品用乙腈沉淀处理,上清液过C18富集柱,用甲醇提取多拉菌素并进行衍生化反应,以反向HPLC测定猪血清中的药物浓度。药代动力学参数用计算机程序MCPKP进行处理。结果表明,动物经静脉和肌肉注射给药后,血浆药物浓度分别可测至30d和25d,2种途径的药物浓度时间曲线均符合二室开放模型。主要药代动力学参数为:静脉注射T1/2α(1.092±0.66)d,T1/2β(6.11±2.73)d,AUC(274.19±119.89)μg/(L·d);肌肉注射T1/2α(0.056±0.022)d,T1/2β(3.20±1.34)d,AUC(223.51±65.20)μg/(L·d),CMAX(28.99±10.69)μg/L,Tp(1.24±0.87)d。多拉菌素肌肉注射的生物利用度为81.5%。结果显示多拉菌素在猪体内具有吸收分布较迅速、体内分布容积大、消除缓慢和生物利用度相对较高的特点,提示多拉菌素在猪体内作用的长效性主要由该化合物的自身特性所决定,而与给药途径和使用的溶剂关系不大,研究结果对指导临床正确用药具有重要意义。  相似文献   

脾虚仔猪口服左旋氧氟沙星的"辨证药动学"研究     

李英伦  刘开永  胡廷秀 《畜牧兽医学报》2005,36(7):727-731

15头健康仔猪，分3组，每组5头：即健康组、脾虚组和四君子汤反证组。按20mg／kg的剂量内服进行左旋氧氟沙星的辨证药动学研究。高效液相色谱法测定血浆中药物浓度，3p97药代动力学程序处理药时数据。健康组和脾虚组药动学数据符合一级吸收一室模型，四君子汤反证组药动学数据符合一级吸收二室模型。试验结果表明：仔猪脾虚状态下明显影响左旋氧氟沙星内服给药的药动学特征(PK)；四君子汤可使脾虚仔猪异常的左旋氧氟沙星的药动学特征得到恢复，为验证“辨证药动学”假说和完善中西兽医结合提供了进一步的科学依据。  相似文献   

泰地罗新注射液在藏香猪体内的药物动力学研究     

赵森  何斌 《中国兽药杂志》2018,52(11):34-39

为研究泰地罗新在藏香猪体内的药物动力学特征,了解其在藏香猪体内的吸收、分布、转化及排泄规律,为泰地罗新注射液的临床合理用药提供参考。本试验选取8头藏香猪,泰地罗新单剂量注射给药,不同时间点采集藏香猪血液,利用高效液相色谱法测定血浆中药物浓度。结果表明：泰地罗新注射给药(4 mg/kg.bw)后,泰地罗新在藏香猪体内的药-时曲线符合有吸收三室开放模型,其主要药动学参数为：Tmax为0.457±0.143h,Cmax为0.759±0.192 μg/mL,t1/2为120.518±10.181h,AUC为22.224±2.641μg.h/mL。表明泰地罗新注射给药后,在藏香猪体内吸收迅速,消除较为缓慢。  相似文献   

Comparison of the pharmacokinetic profiles of two different amphotericin B formulations in healthy dogs          下载免费PDF全文

B. Bingöl  T. Bakirel 《Journal of veterinary pharmacology and therapeutics》2018,41(1):e16-e21

This study was conducted to compare the pharmacokinetic profiles of conventional (Fungizone^®) and liposomal amphotericin B (AmBisome^®) formulations in order to predict their therapeutic properties, and evaluate their potential differences in veterinary treatment. For this purpose, twelve healthy mixed breed dogs received both drugs at a dose of 0.6 mg/kg by intravenous infusion over a 4‐min period in a total volume of 40 ml. Blood samples were collected at 0, 0.5, 1, 1.5, 2, 3, 4, 8, 12, 24, 48, 72 and 96 hr after dosing, and concentrations of drug in plasma were determined by high‐performance liquid chromatography (HPLC). Pharmacokinetics was described by a two‐compartment model. Although both formulations were administered at the same doses (0.6 mg/kg), the plasma pharmacokinetics of liposomal amphotericin B differed significantly from those of amphotericin B deoxycholate in healthy dogs (p < .05). Liposomal amphotericin B showed markedly higher peak plasma concentrations (approximately ninefold greater) and higher area under the plasma concentration curve values (approximately 14‐fold higher) compared to conventional formulation. It is concluded that AmBisome^® reached higher plasma concentration and lower distribution volume and had a longer half‐life compared to Fungizone^®, and therefore, AmBisome^® is reported to be an appropriate and effective choice for the treatment of systemic mycotic infections in dogs.  相似文献